title: Vaccinia-related kinase 1 (VRK1) confers resistance to DNA-damaging agents in human breast cancer by affecting DNA damage response.
abstract: Vaccinia-related kinase 1 (VRK1) belongs to a group of sixteen kinases associated to a poorer prognosis in human breast carcinomas, particularly in estrogen receptor positive cases based on gene expression arrays. In this work we have studied the potential molecular mechanism by which the VRK1 protein can contribute to a poorer prognosis in this disease. For this aim it was first analyzed by immunohistochemistry the VRK1 protein level in normal breast and in one hundred and thirty six cases of human breast cancer. The effect of VRK1 to protect against DNA damage was determined by studying the effect of its knockdown on the formation of DNA repair foci assembled on 53BP1 in response to treatment with ionizing radiation or doxorubicin in two breast cancer cell lines. VRK1 protein was detected in normal breast and in breast carcinomas at high levels in ER and PR positive tumors. VRK1 protein level was significantly lower in ERBB2 positive cases. Next, to identify a mechanism that can link VRK1 to poorer prognosis, VRK1 was knocked-down in two breast cancer cell lines that were treated with ionizing radiation or doxorubicin, both inducing DNA damage. Loss of VRK1 resulted in reduced formation of DNA-damage repair foci complexes assembled on the 53BP1 scaffold protein, and this effect was independent of damaging agent or cell type. This observation is consistent with detection of high VRK1 protein levels in ER and PR positive breast cancers. We conclude that VRK1 can contribute to make these tumors more resistant to DNA damage-based therapies, such as ionizing radiation or doxorubicin, which is consistent with its association to a poor prognosis in ER positive breast cancer. VRK1 is potential target kinase for development of new specific inhibitors which can facilitate sensitization to other treatments in combination therapies; or alternatively be used as a new cancer drugs.
authors.affiliation: Experimental Therapeutics and Translational Oncology Program, Instituto de Biología Molecular y Celular del Cáncer, Consejo Superior de Investigaciones Científicas (CSIC), Universidad de Salamanca, Salamanca, Spain.
authors.forename: Marcella
authors.initials: M
authors.lastname: Salzano
authors.forename: Marta
authors.initials: M
authors.lastname: Vázquez-Cedeira
authors.forename: Marta
authors.initials: M
authors.lastname: Sanz-García
authors.forename: Alberto
authors.initials: A
authors.lastname: Valbuena
authors.forename: Sandra
authors.initials: S
authors.lastname: Blanco
authors.forename: Isabel F
authors.initials: IF
authors.lastname: Fernández
authors.forename: Pedro A
authors.initials: PA
authors.lastname: Lazo
mesh_terms: D001940:Breast / Q000201:enzymology; D001943:Breast Neoplasms / Q000737:chemistry / Q000201:enzymology*; D002277:Carcinoma / Q000737:chemistry / Q000201:enzymology*; D045744:Cell Line, Tumor; D004249:DNA Damage; D004260:DNA Repair / Q000235:genetics; D004317:Doxorubicin; D005260:Female; D055785:Gene Knockdown Techniques; D006801:Humans; D047908:Intracellular Signaling Peptides and Proteins / Q000032:analysis* / Q000235:genetics / Q000378:metabolism*; D011379:Prognosis; D017346:Protein Serine-Threonine Kinases / Q000032:analysis* / Q000235:genetics / Q000378:metabolism*; D011839:Radiation, Ionizing; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000032:analysis; D011960:Receptors, Estrogen / Q000032:analysis; D011980:Receptors, Progesterone / Q000032:analysis; D000071857:Tumor Suppressor p53-Binding Protein 1
chemical_list: D004317:Doxorubicin; D047908:Intracellular Signaling Peptides and Proteins; D017346:Protein Serine-Threonine Kinases; D018719:Erb-b2 Receptor Tyrosine Kinases; D011960:Receptors, Estrogen; D011980:Receptors, Progesterone; D000071857:Tumor Suppressor p53-Binding Protein 1; C498301:TP53BP1 protein, human; C508053:ERBB2 protein, human; C109890:VRK1 protein, human
references.citation: Mol Oncol. 2007 Jun;1(1):84-96
references.pmid: 18516279
references.citation: J Cell Sci. 2008 Sep 15;121(Pt 18):3035-41
references.pmid: 18713830
references.citation: Breast Cancer Res. 2011 Sep 13;13(5):R87
references.pmid: 21914172
references.citation: DNA Repair (Amst). 2004 Aug-Sep;3(8-9):945-52
references.pmid: 15279780
references.citation: Oncogene. 2004 Nov 25;23(55):8950-8
references.pmid: 15378002
references.citation: Lung Cancer. 2007 Dec;58(3):303-9
references.pmid: 17689819
references.citation: Clin Cancer Res. 2007 Aug 1;13(15 Pt 1):4429-34
references.pmid: 17671126
references.citation: Mol Cancer Res. 2006 Mar;4(3):177-85
references.pmid: 16547155
references.citation: J Biol Chem. 2004 Jun 25;279(26):27458-65
references.pmid: 15105425
references.citation: J Biol Chem. 2011 Jun 24;286(25):22131-8
references.pmid: 21543316
references.citation: PLoS One. 2008 Feb 20;3(2):e1642
references.pmid: 18286197
references.citation: Mol Cell Biol. 2004 Dec;24(23):10366-80
references.pmid: 15542844
references.citation: Mol Cancer. 2013 May 24;12:45
references.pmid: 23705792
references.citation: Mol Cell Biol. 2007 Oct;27(20):7273-83
references.pmid: 17709393
references.citation: Cancer Res. 2008 Feb 1;68(3):767-76
references.pmid: 18245477
references.citation: Mol Biol Cell. 2006 May;17(5):2451-64
references.pmid: 16495336
references.citation: Cell Signal. 2011 Aug;23(8):1267-72
references.pmid: 21514377
references.citation: BMC Clin Pathol. 2013 Oct 01;13(1):23
references.pmid: 24079673
references.citation: Structure. 2009 Jan 14;17(1):128-38
references.pmid: 19141289
references.citation: Mol Cell Biol. 2010 Oct;30(19):4687-97
references.pmid: 20679487
references.citation: J Biol Chem. 2012 Feb 17;287(8):5278-89
references.pmid: 22194607
references.citation: J Biol Chem. 2012 Jul 6;287(28):23757-68
references.pmid: 22621922
references.citation: Oncotarget. 2013 Oct;4(10):1572-81
references.pmid: 24197907
references.citation: Science. 2002 Nov 15;298(5597):1435-8
references.pmid: 12364621
references.citation: J Biol Chem. 2012 Dec 14;287(51):42739-50
references.pmid: 23105117
references.citation: Oncogene. 2000 Jul 27;19(32):3656-64
references.pmid: 10951572
references.citation: PLoS One. 2008 Aug 20;3(8):e2994
references.pmid: 18714348
references.citation: Cold Spring Harb Perspect Biol. 2010 Jun;2(6):a001198
references.pmid: 20516129
references.citation: Mol Cell Biol. 2006 Jul;26(13):4782-93
references.pmid: 16782868
references.citation: Proc Natl Acad Sci U S A. 2007 Dec 18;104(51):20523-8
references.pmid: 18077363
references.citation: Cancer Res. 2009 Feb 15;69(4):1302-13
references.pmid: 19190339
references.citation: Arch Biochem Biophys. 2007 Sep 1;465(1):219-26
references.pmid: 17617371
references.citation: PLoS One. 2008 Feb 20;3(2):e1660
references.pmid: 18286207
references.citation: Cell Mol Life Sci. 2012 Nov;69(22):3881-93
references.pmid: 22752157
references.citation: Oncotarget. 2010 Dec;1(8):691-9
references.pmid: 21321378
references.citation: J Biol Inorg Chem. 2013 Apr;18(4):473-82
references.pmid: 23483238
references.citation: Mol Cell Biol. 2009 Mar;29(5):1189-201
references.pmid: 19103756
references.citation: PLoS One. 2011 Feb 28;6(2):e17320
references.pmid: 21386980
references.citation: Cancer Cell. 2006 Dec;10(6):515-27
references.pmid: 17157791
references.citation: Breast Cancer Res. 2013 Oct 01;15(5):R92
references.pmid: 24286369
references.citation: PLoS One. 2008 Jul 09;3(7):e2649
references.pmid: 18612383
references.citation: Cancer Res. 2006 Jul 15;66(14):7095-102
references.pmid: 16849555
references.citation: PLoS One. 2011;6(8):e23235
references.pmid: 21829721
references.citation: Nat Commun. 2013;4:1701
references.pmid: 23591868
references.citation: EMBO J. 2007 Jan 10;26(1):132-43
references.pmid: 17170708
references.citation: Oncogenesis. 2013 Jun 03;2:e48
references.pmid: 23732708
references.citation: Drug Discov Today. 2007 May;12(9-10):365-72
references.pmid: 17467572
references.citation: Cell Death Dis. 2013 Feb 28;4:e513
references.pmid: 23449449
references.citation: FEBS J. 2006 Jun;273(11):2487-504
references.pmid: 16704422
references.citation: Mol Cell Biol. 2007 Dec;27(24):8533-46
references.pmid: 17938195
references.citation: Mol Biol Cell. 2013 Feb;24(3):373-84
references.pmid: 23223570
references.citation: Mol Cancer Ther. 2006 Nov;5(11):2606-12
references.pmid: 17088437